logo

MRVI

Maravai
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
Signals Analysis
Buy signal 3
Sell signal 1
Consensus Rating "Strong Buy"
Significant Net Income Decline
Revenue Beats Expectation
EPS Beats Expectation

Key Stats

0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000

About MRVI

Maravai Lifesciences Holdings, Inc.

A leading life sciences company that provides products to develop drug therapies, diagnostics, novel vaccines, and supports research on diseases

Pharmaceutical
08/25/2020
11/20/2020
NASDAQ Stock Exchange
570
12-31
Common stock
10770 Wateridge Circle Suite 200, San Diego, California 92121
--
Maravai Lifesciences Holdings, Inc., was incorporated in Delaware on August 25, 2020. The company is a leading life sciences company that provides key products to support drug therapies, diagnostics, development of novel vaccines, and supporting research in human diseases.

Earnings Call

Company Financials

EPS

MRVI has released its 2025 Q1 earnings. EPS was reported at -0.08, versus the expected -0.07, missing expectations. The chart below visualizes how MRVI has performed over recent quarters, highlighting trends in earnings surprises.

Revenue & Expenses

MRVI has released its 2025 Q1 earnings report, with revenue of 46.85M, reflecting a YoY change of -27.00%, and net profit of -52.85M, showing a YoY change of -133.04%. The Sankey diagram below clearly presents MRVI's revenue sources and cost distribution.

Forecast

Wall Street Opinions

Price Target

Volume Profile

Trade Flow Insight

Seasonals

Community Forum

Loading...

Related News

No articles available

Related Symbols

You can ask Aime